의료 코딩용 AI 시장 - 세계 산업 규모, 점유율, 동향, 기회, 예측 : 구성요소별, 최종사용별, 지역별 및 경쟁(2021-2031년)

The Global AI In Medical Coding Market is projected to expand from USD 2.45 Billion in 2025 to USD 4.22 Billion by 2031, reflecting a compound annual growth rate of 9.49%. This sector involves utilizing artificial intelligence technologies, including natural language processing and machine learning, to automatically convert medical documentation into standardized alphanumeric codes for billing and diagnostic purposes. The primary factors driving this market's growth include the surging volume of healthcare data and the critical need for providers to minimize claim denials resulting from human error. Additionally, the adoption of these technologies is being accelerated by a persistent global shortage of skilled medical coders and the necessity to streamline revenue cycle management by lowering administrative operational costs.

According to the American Medical Association, 31% of physicians reported in 2025 that they were using AI specifically for documenting medical charts and billing codes. Despite this increasing adoption, the market faces significant obstacles regarding data accuracy and liability risks associated with AI-generated errors. The risk of algorithmic "hallucinations" or the misinterpretation of complex clinical nuances requires continuous human oversight, which can complicate the implementation process and discourage organizations from fully relying on autonomous coding solutions.

Market Driver

The urgent need to mitigate claim denials and improve payment accuracy acts as a primary catalyst for the adoption of AI in medical coding. Healthcare providers are increasingly applying machine learning algorithms to audit clinical documentation against intricate payer rules prior to claim submission, thereby preventing revenue leakage associated with human oversight. This shift is critical as denial rates rise due to evolving regulatory standards and stricter payer adjudication processes, necessitating tools that can preemptively identify discrepancies. In the 'State of Claims 2024' report by Experian Health from June 2024, 73% of healthcare providers indicated that claim denials are increasing, highlighting the urgent need for automated solutions that ensure coding precision and compliance.

Simultaneously, there is an escalating demand for operational efficiency to address the chronic shortage of skilled medical coders and increasing data volumes. Organizations are deploying autonomous coding platforms to handle high-volume, repetitive charts, allowing human staff to focus on complex cases and reducing the administrative burden that leads to workforce burnout. The capability of these technologies to process vast datasets rapidly is transforming revenue cycle management by significantly shortening billing cycles. For example, a February 2024 press release from Fathom noted that their AI technology achieved a 90% automation rate for emergency medicine encounters, demonstrating the capacity of these tools to manage workload volume. Furthermore, the financial commitment to scaling these solutions is evident; CodaMetrix secured $40 million in Series B funding in 2024 to further develop its autonomous medical coding platform.

Market Challenge

The significant challenge of data accuracy and the potential for liability arising from AI-generated errors is directly hampering the growth of the Global AI In Medical Coding Market. Healthcare organizations are hesitant to fully integrate autonomous coding solutions because algorithmic hallucinations or the misinterpretation of complex clinical nuances can lead to severe billing discrepancies and legal repercussions. This lack of reliability forces providers to maintain continuous human oversight to validate AI outputs, which counteracts the primary objective of reducing administrative operational costs. Consequently, the necessity for manual verification diminishes the return on investment and slows the speed of implementation across health systems.

According to the Medical Group Management Association, 44% of medical practice leaders using AI tools reported in 2025 that the technology had not reduced their staff workload. This statistic underscores the operational impact of the accuracy challenge, as the persistent need for human intervention to correct or verify AI-generated data prevents organizations from realizing the efficiency gains promised by automation. This failure to alleviate the administrative burden creates a significant barrier to the widespread adoption of AI in the medical coding sector.

Market Trends

The Integration of Generative AI and Large Language Models (LLMs) represents a fundamental shift in technical capability, moving beyond basic keyword extraction to the deep contextual understanding of unstructured clinical narratives. Unlike earlier rule-based systems, these advanced models analyze physician notes, discharge summaries, and operative reports to autonomously generate accurate code assignments while simultaneously summarizing complex medical histories for validator review. This trend addresses the interpretative gap in coding, allowing for the precise handling of nuanced clinical data that traditional algorithms often misclassify. The industry confidence in this technological leap is substantial; according to the 'Revenue cycle leaders see gen AI's medical coding potential' report by Akasa in October 2024, 65% of surveyed health system revenue cycle leaders believe that generative AI will have a substantial effect on their medical coding operations.

Concurrent with generative capabilities, the Utilization of AI for Risk Adjustment Coding Accuracy is reshaping value-based care strategies by uncovering chronic conditions that manual processes frequently overlook. In this model, algorithms retrospectively and prospectively audit patient charts to identify undocumented Hierarchical Condition Categories (HCCs), ensuring that health plans receive appropriate reimbursement commensurate with patient acuity. This application is distinct from simple denial prevention as it focuses on revenue integrity and long-term population health data quality rather than transactional claim acceptance. The tangible impact of this trend is evident in operational outcomes; according to the 'Coding at a crossroads: Unpacking the next generation of AI for risk adjustment' article by RISE Health in November 2024, a health plan implementing deep learning AI for risk adjustment reviews achieved a 27% increase in ICD capture, directly improving their risk score accuracy and financial performance.

Key Market Players

• 3M Company
• Nuance Communications, Inc.
• MedsIT Nexus Inc.
• Optum, Inc.
• Oracle Corporation
• Olive Technologies, Inc.
• Medicodio Inc.
• Fathom, Inc.
• Wolters Kluwer N.V.
• Medisys Data Solutions Inc.

Report Scope

In this report, the Global AI In Medical Coding Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

AI In Medical Coding Market, By Component

• In-House
• Outsourced

AI In Medical Coding Market, By End Use

• Healthcare Providers
• Medical Billing
• Companies
• Payers

AI In Medical Coding Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global AI In Medical Coding Market.

Available Customizations:

Global AI In Medical Coding Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global AI In Medical Coding Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Component (In-House, Outsourced)
  • 5.2.2. By End Use (Healthcare Providers, Medical Billing, Companies, Payers)
  • 5.2.3. By Region
  • 5.2.4. By Company (2025)
• 5.3. Market Map

6. North America AI In Medical Coding Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Component
  • 6.2.2. By End Use
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States AI In Medical Coding Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Component
      • 6.3.1.2.2. By End Use
  • 6.3.2. Canada AI In Medical Coding Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Component
      • 6.3.2.2.2. By End Use
  • 6.3.3. Mexico AI In Medical Coding Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Component
      • 6.3.3.2.2. By End Use

7. Europe AI In Medical Coding Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Component
  • 7.2.2. By End Use
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany AI In Medical Coding Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Component
      • 7.3.1.2.2. By End Use
  • 7.3.2. France AI In Medical Coding Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Component
      • 7.3.2.2.2. By End Use
  • 7.3.3. United Kingdom AI In Medical Coding Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Component
      • 7.3.3.2.2. By End Use
  • 7.3.4. Italy AI In Medical Coding Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Component
      • 7.3.4.2.2. By End Use
  • 7.3.5. Spain AI In Medical Coding Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Component
      • 7.3.5.2.2. By End Use

8. Asia Pacific AI In Medical Coding Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Component
  • 8.2.2. By End Use
  • 8.2.3. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China AI In Medical Coding Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Component
      • 8.3.1.2.2. By End Use
  • 8.3.2. India AI In Medical Coding Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Component
      • 8.3.2.2.2. By End Use
  • 8.3.3. Japan AI In Medical Coding Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Component
      • 8.3.3.2.2. By End Use
  • 8.3.4. South Korea AI In Medical Coding Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Component
      • 8.3.4.2.2. By End Use
  • 8.3.5. Australia AI In Medical Coding Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Component
      • 8.3.5.2.2. By End Use

9. Middle East & Africa AI In Medical Coding Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Component
  • 9.2.2. By End Use
  • 9.2.3. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia AI In Medical Coding Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Component
      • 9.3.1.2.2. By End Use
  • 9.3.2. UAE AI In Medical Coding Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Component
      • 9.3.2.2.2. By End Use
  • 9.3.3. South Africa AI In Medical Coding Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Component
      • 9.3.3.2.2. By End Use

10. South America AI In Medical Coding Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Component
  • 10.2.2. By End Use
  • 10.2.3. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil AI In Medical Coding Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Component
      • 10.3.1.2.2. By End Use
  • 10.3.2. Colombia AI In Medical Coding Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Component
      • 10.3.2.2.2. By End Use
  • 10.3.3. Argentina AI In Medical Coding Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Component
      • 10.3.3.2.2. By End Use

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global AI In Medical Coding Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. 3M Company
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Nuance Communications, Inc.
• 15.3. MedsIT Nexus Inc.
• 15.4. Optum, Inc.
• 15.5. Oracle Corporation
• 15.6. Olive Technologies, Inc.
• 15.7. Medicodio Inc.
• 15.8. Fathom, Inc.
• 15.9. Wolters Kluwer N.V.
• 15.10. Medisys Data Solutions Inc.

16. Strategic Recommendations

17. About Us & Disclaimer